Abstract

Eukaryotic green algae have become an increasingly popular platform for recombinant proteins production. In particular, Chlamydomonas reinhardtii, has garnered increased attention for having the necessary biochemical machinery to produce vaccines, human antibodies and next generation cancer targeting immunotoxins. While it has been shown that chloroplasts contain chaperones, peptidyl prolylisomerases and protein disulfide isomerases that facilitate these complex proteins folding and assembly, little has been done to determine which processes serve as rate-limiting steps for protein accumulation. In other expression systems, as Escherichia coli, Chinese hamster ovary cells, and insect cells, recombinant protein accumulation can be hampered by cell’s inability to fold the target polypeptide into the native state, resulting in aggregation and degradation. To determine if chloroplasts’ ability to oxidize proteins that require disulfide bonds into a stable conformation is a rate-limiting step of protein accumulation, three recombinant strains, each expressing a different recombinant protein, were analyzed. These recombinant proteins included fluorescent GFP, a reporter containing no disulfide bonds; Gaussia princeps luciferase, a luminescent reporter containing disulfide bonds; and an immunotoxin, an antibody-fusion protein containing disulfide bonds. Each strain was analyzed for its ability to accumulate proteins when supplemented with selenocystamine, a small molecule capable of catalyzing the formation of disulfide bonds. Selenocystamine supplementation led to an increase in luciferase and immunotoxin but not GFP accumulation. These results demonstrated that selenocystamine can increase the accumulation of proteins containing disulfide bonds and suggests that a rate-limiting step in chloroplast protein accumulation is the disulfide bonds formation in recombinant proteins native structure.

Highlights

  • The advent of recombinant DNA technologies and the ability to transform microbial organisms with synthetic DNA has revolutionized the pharmaceutical industry (Walsh 2014)

  • In this work we set out to evaluate the ability of a small molecule oxidant, selenocystamine, to increase protein accumulation of heterologous proteins that require the formation of disulfide bonds in algal chloroplasts

  • Chloroplasts of C. reinhardtii were transformed with genes coding for Gluc (Goerke et al 2008) that require disulfide bonds to be active, or green fluorescent protein (GFP) (Prisco et al 2005) that does not

Read more

Summary

Introduction

The advent of recombinant DNA technologies and the ability to transform microbial organisms with synthetic DNA has revolutionized the pharmaceutical industry (Walsh 2014). Algae offer attractive production features, including photosynthetic growth (Franklin and Mayfield 2004), ease of genetic manipulations (Grossman 2000), and unique biochemical compartments (Tran et al 2009). These features allow green algae to produce complex heterologous proteins at a fraction of the cost of traditional protein expression platforms (Franklin and Mayfield 2004). C. reinhardtii has been used to demonstrate the ability of chloroplasts to facilitate the production of full-length human antibodies (Tran et al 2013b), industrial enzymes (Rasala et al 2012), and vaccine molecules (Gregory et al 2012). Chloroplasts have the machinery to produce and assemble these complex proteins with multiple disulfide bonds (Tran et al 2013a, b), little has been done to determine which steps of complex protein accumulation are rate-limiting

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call